Table 3.
Results of univariate analyses for risk factors associated with POUR.
| Urethral catheter-free intraoperative management | Preoperatively placed urethral catheter | |||||
| OR | 95%-CI | p | OR | 95%-CI | p | |
| Sex | 1.33 | 0.41–4.37 | 0.64 | 1.12 | 0.48–2.61 | 0.56 |
| Age | 0.99 | 0.96–1.04 | 0.93 | 1.06 | 0.97–1.16 | 0.17 |
| ASA physical status classification system | ||||||
| ASA I⁎⁎ | Ref. | – | – | – | ||
| ASA II | 0.23 | 0.02–2.59 | 0.24 | Ref. | ||
| ASA III | 0.56 | 0.14–2.19 | 0.4 | 0.12 | 0.01–1.08 | 0.06 |
| Urological relevant secondary diagnosis* | 2.42 | 0.62–9.54 | 0.21 | 2.93 | 0.48–18 | 0.15 |
| Nocturia | 0.9 | 0.48–1.69 | 0.74 | 0.83 | 0.36–1.89 | 0.65 |
| IPSS: Total IPSS score | 0.97 | 0.84–1.11 | 0.62 | 0.97 | 0.81–1.17 | 0.76 |
| IPSS: QoL due to urinary symptoms | 1.02 | 0.6–1.73 | 0.95 | 0.51 | 0.18–1.45 | 0.21 |
| Post void residual prior surgery | 0.99 | 0.96–1.03 | 0.74 | 1.01 | 0.99–1.03 | 0.07 |
| Prostate volume† | 1.01 | 0.95–1.01 | 0.8 | 1.02 | 0.96–1.07 | 0.56 |
| Surgical level | ||||||
| Cervical⁎⁎ | Ref. | Ref. | ||||
| Lumbo-thoracic | 4.62 | 0.38–55.51 | 0.23 | 3.5 | 0.59–20.81 | 0.17 |
| Lumbo-sacral | 0.33 | 0.04–2.96 | 0.32 | 0 | 0 | 0.99 |
| Surgery duration | 1.02 | 1.00–1.03 | 0.01 | 0.99 | 0.98–1.01 | 0.66 |
| Perioperative intravenous infusion | 1 | 1–1.01 | 0.04 | 1 | 0.99–1.01 | 0.41 |
| Surgery-related adverse events | 1.21 | 0.2–7.4 | 0.83 | 1.17 | 0.62–2.11 | 0.43 |
POUR=postoperative urinary retention; ASA=American Society of Anesthesiologists; IPSS=International Prostate Symptom Score; QoL=Quality of Life; OR=Odds ratio; CI=confidence interval.
Urological relevant secondary diagnosis included hysterectomy, colpo-sacropexy, diabetes, polyneuropathy, stroke, Parkinson's disease, and colectomy.
Used reference value for categorial variables.
Male patients only.